Cost-effectiveness of oral anticoagulant therapy in patients with device-detected atrial fibrillation

Europace · Published 2026-06-01 · DOI 10.1093/europace/euag105.1262

Free full text

Authors (4)

A K Winsten, V Langen, K E J Airaksinen, K Teppo

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Winsten, A., Langen, V., Airaksinen, K., et al. (2026). Cost-effectiveness of oral anticoagulant therapy in patients with device-detected atrial fibrillation. Europace. https://doi.org/10.1093/europace/euag105.1262

Related articles

• Pulsed field ablation as first-line therapy for the treatment of atrial fibrillation: a FARADISE sub-analysis · Europace · 2026 · Same journal
• Angioplasty for pulmonary vein stenosis after atrial fibrillation ablation · Europace · 2026 · Same journal
• Vectorcardiography reflects left ventricular reverse remodeling after cardiac resynchronization therapy for both left bundle branch area pacing and biventricular pacing · Europace · 2026 · Same journal
• Irrigated catheter ablation in pediatric ebstein anomaly: acute success and technical perspective from a lower middle income country · Europace · 2026 · Same journal
• The "Jellyfish Method": an in-vitro validated troubleshooting technique for anatomical challenges in pentaspline PFA · Europace · 2026 · Same journal
• Interval vs non-interval pulsed-field ablation: reduced microembolic signals and size in a porcine in vivo model · Europace · 2026 · Same journal
• Impact of raised body mass index on bi-atrial structure, function, and electrophysiology in patients with atrial fibrillation · Europace · 2026 · Same journal
• Late effect after PVC ablation: more than a myth? · Europace · 2026 · Same journal
• Nationwide trends in left bundle branch area pacing in South Korea · Europace · 2026 · Same journal
• New ECG signal derivation reconstruction from ppg using deep learning network AI approach · Europace · 2026 · Same journal